- Main
- News centre
- Funds
- Management companies
- Deals
- Portfolio companies
- Consultants
- IPO/SPO
- Projects
- Comments
- Preqveca monthly
- IPO monthly
- Preqveca polls
- PREQVECA Awards
- Macro indicators
- Knowledge bank
- Newsletters
- About us
- Subscription
Details
Name | Pharmacy Chain 36.6 / SPO-3 |
Placement specification | common stock |
Placement type | SPO |
Subscription type | Public offering |
Status | Completed |
End of placement | 28.06.2010 |
Placement amount | 10 000 000 |
Placement volume, mln. USD | 31 |
Offering price, USD | 3.10 |
Price change from the placement date | -66.13% |
Trading floor | MICEX, RTS |
Investment banks | EUROFINANSY |
Country of operation | Russia |
Industry | Pharmaceutical industry |
Issuer
"Pharmacy Chain 36.6" is a holding company of the Group, which incorporates 36.6 drugstore chain (the biggest in Russia) and pharmaceutical producer OAO Verofarm.
Web-site: to the issuer site
Other IPO / SPO Issuer
Issuer news
-
17.08.2021
Cbonds: Pharmacy Chain 36.6 announces about RAS net loss for 6 months of 2021 equal to RUB -299.24 million.
-
19.03.2021
Cbonds: RAS. Pharmacy Chain 36.6. December 31, 2020: total assets’ increase is 19.07 % YoY
-
07.05.2019
Cbonds: Gazprom’s, Tattelecom’s, Mostotrest’s, Morion’s, IAPO’s, Irkutskenergo’s, Neftegazholding’s, RZD’s, Russian Aquaculture’s, Pioneer Group’s, Pharmacy Chain 36.6’s IFRS results were published
-
22.06.2016
Cbonds: Pharmacy Chain 36.6’s RAS results were published
-
06.06.2012
Cbonds: Pharmacy 36.6 redeems restructured bond issue
-
03.06.2011
Cbonds: Pharmacy 36.6 to sell exchange bonds in summer
-
18.11.2010
Cbonds: Series BO-02 and BO-03 exchange bonds of Pharmacy Chain 36.6 registered on MICEX
Stock details
Stock | APTEChNAYa SET 36,6 |
Type | common stock |
Par value, RUB | 0.64 |
State registration number | 1-01-07335-A |
ISIN | RU0008081765 |
Announced volume | 7 630 433 826 |
Free-float | 0.06 |
MICEX
Ticker:
RU14APTK1007
Quotation list:
B
RTS
Ticker:
APTK
Quotation list:
B
Price dynamics
MICEX | RTS |
|
|
Dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|